A study by Boston University researchers found no increased risk of miscarriage associated with the COVID-19 vaccine among individuals planning a pregnancy. This encouraging evidence supports the safety of preconception vaccination and is consistent with health authorities’ recommendations for vaccination of people planning pregnancy.
The new study is the first to prospectively assess the relationship between bias and bias. COVID-19 (new coronavirus infection) We found that vaccinating both partners and having a miscarriage slightly reduced the risk of miscarriage among vaccinated partners trying to conceive.
In many studies, It is shown COVID-19 vaccines do not cause infertility or increase the risk of pregnancy-related problems, including miscarriage.Despite this evidence, people still on guard About the potential negative effects of vaccines on pregnancy.
A recent study conducted by researchers at the Boston University School of Public Health (BUSPH) provided more comprehensive information about the safety of COVID-19 vaccines for individuals considering pregnancy.
It was published in the magazine human reproductionthe study found no increased risk of early or late miscarriage as a result of either the man or the woman’s partner receiving the COVID-19 vaccine before pregnancy.
Insights from new research on pre-pregnancy vaccine safety
This study is the first to assess the risk of early miscarriage (<8 weeks gestation) following preconception COVID-19 vaccination, and the first to assess vaccination and miscarriage in men. The researchers hope these results will be useful information for individuals planning pregnancy and health care providers.
“These findings should be replicated in other populations, but are reassuring for couples planning pregnancy,” says lead author Jennifer Eland, an epidemiology doctoral student at BUSPH at the time of the study. .
Study details and results
For this study, Yland and colleagues analyzed survey data on COVID-19 vaccination and miscarriage among male and female participants of the BUSPH-based Online Pregnancy Study (PRESTO). National Institutes of Health– A funded study that enrolls women who wish to become pregnant and follows them from before pregnancy until 6 months after giving birth. Participants in this new analysis included 1,815 women in the United States and Canada who were followed in the study from December 2020 to November 2022. They were observed from the first positive pregnancy test until miscarriage or other event (e.g. induced abortion, ectopic pregnancy) occurred. , or 20 weeks of pregnancy)—whichever comes first.
Among female participants, 75% had received at least one dose of a coronavirus vaccine before becoming pregnant. Almost a quarter of pregnancies led to miscarriage, 75% of which occurred before 8 weeks of pregnancy, but there was no increased risk.
The risk of miscarriage was 26.6% for unvaccinated female participants, 23.9% for female participants who received one dose of vaccine before pregnancy, and 24.5% for female participants who completed the full first dose before pregnancy. and 22.1% among female participants who completed the vaccination series. 20.1% of women received only one dose of the two-dose vaccine three months before pregnancy.
“The miscarriage rate among vaccinated people was not only comparable to that among PRESTO participants who became pregnant before the pandemic, but also that the risk of miscarriage among vaccinated people was higher than that of unvaccinated people. “Our data showed that it was slightly lower than the previous year,” Yland said.
Federal health officials continue to recommend COVID-19 vaccination for people planning pregnancy, emphasizing that the benefits of COVID-19 vaccination outweigh the potential risks of vaccination before or during pregnancy. ing.
Reference: “Prospective Cohort Study of Preconception COVID-19 Vaccination and Miscarriage” Jennifer J Yland, Amelia K Wesselink, Annette K Regan, Elizabeth E Hatch, Kenneth J Rothman, David A Savitz, Tanran R Wang, Krista By F Huybrechts, Sonia Hernández-Diaz, Michael L. Eisenberg, Lauren A. Wise, October 20, 2023. human reproduction.
DOI: 10.1093/hamrep/dead211
The study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, and the National Science Foundation.
Source: scitechdaily.com
